Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals.

Viecelli AK, Howell M, Tong A, Teixeira-Pinto A, O'Lone E, Ju A, Craig JC, Hooi LS, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani TJ, Vanholder R, Zuo L, Tordoir J, Pecoits-Filho R, Yuo T, Kopperschmidt P, Smith R, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Nephrol Dial Transplant. 2019 Aug 1. pii: gfz148. doi: 10.1093/ndt/gfz148. [Epub ahead of print]

PMID:
31369099
2.

The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative study.

Zimbudzi E, Lo C, Robinson T, Ranasinha S, Teede HJ, Usherwood T, Polkinghorne KR, Kerr PG, Fulcher G, Gallagher M, Jan S, Cass A, Walker R, Russell G, Johnson G, Zoungas S.

PLoS One. 2019 Jul 15;14(7):e0219685. doi: 10.1371/journal.pone.0219685. eCollection 2019.

3.

Arteriovenous access practices in Australian and New Zealand dialysis units.

Smyth B, Kotwal S, Gallagher M, Gray NA, Polkinghorne KR.

J Vasc Access. 2019 Nov;20(6):740-745. doi: 10.1177/1129729819851061. Epub 2019 May 30.

PMID:
31144566
4.

ESKD or Cancer: Given the Choice, Which Would You Rather Have?

Polkinghorne KR.

Am J Kidney Dis. 2019 Jun;73(6):753-755. doi: 10.1053/j.ajkd.2019.01.037. Epub 2019 Apr 22. No abstract available.

PMID:
31023501
5.

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.

Viecelli AK, Polkinghorne KR, Pascoe EM, Paul-Brent PA, Hawley CM, Badve SV, Cass A, Hooi LS, Kerr PG, Mori TA, Ong LM, Voss D, Johnson DW, Irish AB; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

PLoS One. 2019 Mar 26;14(3):e0213274. doi: 10.1371/journal.pone.0213274. eCollection 2019.

6.

A simple score can identify kidney transplant recipients at high risk of severe infection over the following 2 years.

Dendle C, Polkinghorne KR, Mulley WR, Gan PY, Kanellis J, Stuart RL, Thursky K, Holdsworth SR.

Transpl Infect Dis. 2019 Jun;21(3):e13076. doi: 10.1111/tid.13076. Epub 2019 Apr 22.

PMID:
30875147
7.

Effect of centre- and patient-related factors on uptake of haemodiafiltration in Australia and New Zealand: A cohort study using ANZDATA.

Mac K, Hedley J, Kelly PJ, Lee VW, Agar JWM, Hawley CM, Johnson DW, See EJ, Polkinghorne KR, Rabindranath KS, Sud K, Webster AC.

Nephrology (Carlton). 2019 Mar 5. doi: 10.1111/nep.13574. [Epub ahead of print]

PMID:
30838737
8.

Risk Indices in Deceased-donor Organ Allocation for Transplantation: Review From an Australian Perspective.

Ling JEH, Fink M, Westall G, Macdonald P, Clayton PA, Holdsworth R, Opdam H, Polkinghorne KR, Kanellis J.

Transplantation. 2019 May;103(5):875-889. doi: 10.1097/TP.0000000000002613. Review.

PMID:
30801513
9.

Prevalence of chronic kidney disease in the elderly using the ASPirin in Reducing Events in the Elderly study cohort.

Polkinghorne KR, Wolfe R, Jachno KM, Wetmore JB, Woods RL, McNeil JJ, Nelson MR, Reid CM, Murray AM; ASPREE Investigator Group.

Nephrology (Carlton). 2019 Dec;24(12):1248-1256. doi: 10.1111/nep.13565. Epub 2019 May 7.

10.

Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease.

Lo C, Zimbudzi E, Teede HJ, Kerr PG, Ranasinha S, Cass A, Fulcher G, Gallagher M, Polkinghorne KR, Russell G, Usherwood T, Walker R, Zoungas S.

J Diabetes Complications. 2019 Jan;33(1):63-68. doi: 10.1016/j.jdiacomp.2018.09.020. Epub 2018 Oct 12.

PMID:
30621853
11.

Comparing dialysis centre mortality outcomes across Australia and New Zealand: identifying unusually performing centres 2008-2013.

Kasza J, Polkinghorne KR, Wolfe R, McDonald SP, Marshall MR.

BMC Health Serv Res. 2018 Dec 29;18(1):1007. doi: 10.1186/s12913-018-3832-0.

12.

Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.

Koye DN, Magliano DJ, Reid CM, Pavkov ME, Chadban SJ, McDonald SP, Polkinghorne KR, White S, Paul C, Shaw JE.

Am J Kidney Dis. 2019 Mar;73(3):300-308. doi: 10.1053/j.ajkd.2018.10.005. Epub 2018 Dec 19.

PMID:
30579709
13.

Measurement of Humoral Immune Competence and the Risk of Sinopulmonary Infection in a Cohort of Kidney Transplant Recipients.

Dendle C, Stuart RL, Mulley WR, Polkinghorne KR, Gan PY, Kanellis J, Ngui J, Laurie K, Thursky K, Leung VK, Holdsworth SR.

Transplant Proc. 2018 Dec;50(10):3367-3370. doi: 10.1016/j.transproceed.2018.07.017.

PMID:
30577209
14.

Changes in Body Mass Index and Rates of Death and Transplant in Hemodialysis Patients: A Latent Class Joint Modeling Approach.

Brilleman SL, Moreno-Betancur M, Polkinghorne KR, McDonald SP, Crowther MJ, Thomson J, Wolfe R.

Epidemiology. 2019 Jan;30(1):38-47. doi: 10.1097/EDE.0000000000000931.

PMID:
30499863
15.

Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure.

See EJ, Jayasinghe K, Glassford N, Bailey M, Johnson DW, Polkinghorne KR, Toussaint ND, Bellomo R.

Kidney Int. 2019 Jan;95(1):160-172. doi: 10.1016/j.kint.2018.08.036. Epub 2018 Nov 23.

PMID:
30473140
16.

Patient reported barriers are associated with low physical and mental well-being in patients with co-morbid diabetes and chronic kidney disease.

Zimbudzi E, Lo C, Ranasinha S, Fulcher G, Gallagher M, Jan S, Kerr PG, Teede HJ, Polkinghorne KR, Russell G, Walker RG, Zoungas S.

Health Qual Life Outcomes. 2018 Nov 19;16(1):215. doi: 10.1186/s12955-018-1044-2.

17.

The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort.

Damasiewicz MJ, Lu ZX, Kerr PG, Polkinghorne KR.

BMC Nephrol. 2018 Nov 14;19(1):325. doi: 10.1186/s12882-018-1127-7.

18.

Associations of Chronic Kidney Disease Markers with Cognitive Function: A 12-Year Follow-Up Study.

Sacre JW, Magliano DJ, Zimmet PZ, Polkinghorne KR, Chadban SJ, Anstey KJ, Shaw JE.

J Alzheimers Dis. 2019;70(s1):S19-S30. doi: 10.3233/JAD-180498.

19.

Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.

Lim WH, Johnson DW, Hawley C, Lok C, Polkinghorne KR, Roberts MA, Boudville N, Wong G.

Med J Aust. 2018 Nov 19;209(10):440-446. Epub 2018 Oct 22.

PMID:
30332936
20.

Patient survival on haemodiafiltration and haemodialysis: a cohort study using the Australia and New Zealand Dialysis and Transplant Registry.

See EJ, Hedley J, Agar JWM, Hawley CM, Johnson DW, Kelly PJ, Lee VW, Mac K, Polkinghorne KR, Rabindranath KS, Sud K, Webster AC.

Nephrol Dial Transplant. 2019 Feb 1;34(2):326-338. doi: 10.1093/ndt/gfy209.

PMID:
30124954
21.

Biochemical comparison of 8 h haemodialysis and 4 h haemodiafiltration, and two dialysis membranes, in a randomized cross-over trial.

Choo SZ, Polkinghorne KR, Kerr PG.

Nephrology (Carlton). 2019 May;24(5):542-549. doi: 10.1111/nep.13397.

PMID:
29722110
22.

Natural killer cell function predicts severe infection in kidney transplant recipients.

Dendle C, Gan PY, Polkinghorne KR, Ngui J, Stuart RL, Kanellis J, Thursky K, Mulley WR, Holdsworth S.

Am J Transplant. 2019 Jan;19(1):166-177. doi: 10.1111/ajt.14900. Epub 2018 Jun 13.

PMID:
29708649
23.

Confirmed microsporidial graft infection in a HIV-negative renal transplant recipient: A case report and review of the literature.

Brown M, Longano A, Dendle C, Polkinghorne KR, Kanellis J.

Transpl Infect Dis. 2018 Jun;20(3):e12888. doi: 10.1111/tid.12888. Epub 2018 Apr 10. Review.

PMID:
29570921
24.

Seroresponses and safety of 13-valent pneumococcal conjugate vaccination in kidney transplant recipients.

Dendle C, Stuart RL, Polkinghorne KR, Balloch A, Kanellis J, Ling J, Kummrow M, Moore C, Thursky K, Buttery J, Mulholland K, Gan PY, Holdsworth S, Mulley WR.

Transpl Infect Dis. 2018 Apr;20(2):e12866. doi: 10.1111/tid.12866. Epub 2018 Apr 1.

PMID:
29512234
25.

Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access.

Viecelli AK, Tong A, O'Lone E, Ju A, Hanson CS, Sautenet B, Craig JC, Manns B, Howell M, Chemla E, Hooi LS, Johnson DW, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Hawley CM; SONG-HD Vascular Access Workshop Investigators.

Am J Kidney Dis. 2018 May;71(5):690-700. doi: 10.1053/j.ajkd.2017.12.003. Epub 2018 Feb 23. Review.

PMID:
29478866
26.

Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

Sautenet B, Tong A, Williams G, Hemmelgarn BR, Manns B, Wheeler DC, Tugwell P, van Biesen W, Winkelmayer WC, Crowe S, Harris T, Evangelidis N, Hawley CM, Pollock C, Johnson DW, Polkinghorne KR, Howard K, Gallagher MP, Kerr PG, McDonald SP, Ju A, Craig JC.

Am J Kidney Dis. 2018 Jul;72(1):62-74. doi: 10.1053/j.ajkd.2017.11.010. Epub 2018 Feb 21.

PMID:
29475768
27.

Omega-3 Polyunsaturated Fatty Acid Supplementation to Prevent Arteriovenous Fistula and Graft Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Viecelli AK, Irish AB, Polkinghorne KR, Hawley CM, Johnson DW, Mori TA, Pascoe EM, Strippoli GFM, Lok CE, Palmer SC.

Am J Kidney Dis. 2018 Jul;72(1):50-61. doi: 10.1053/j.ajkd.2017.11.017. Epub 2018 Feb 12.

PMID:
29395485
28.

Endothelial Progenitor Cells and Vascular Health in Dialysis Patients.

Huuskes BM, DeBuque RJ, Polkinghorne KR, Samuel CS, Kerr PG, Ricardo SD.

Kidney Int Rep. 2017 Sep 18;3(1):205-211. doi: 10.1016/j.ekir.2017.09.004. eCollection 2018 Jan. No abstract available.

29.

Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study.

See EJ, Johnson DW, Hawley CM, Pascoe EM, Badve SV, Boudville N, Clayton PA, Sud K, Polkinghorne KR, Borlace M, Cho Y.

Am J Kidney Dis. 2018 Aug;72(2):188-197. doi: 10.1053/j.ajkd.2017.10.019. Epub 2017 Dec 23.

PMID:
29277508
30.

Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review.

Viecelli AK, O'Lone E, Sautenet B, Craig JC, Tong A, Chemla E, Hooi LS, Lee T, Lok C, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Am J Kidney Dis. 2018 Mar;71(3):382-391. doi: 10.1053/j.ajkd.2017.09.018. Epub 2017 Dec 6.

PMID:
29203125
31.

The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled.

Viecelli AK, Mori TA, Roy-Chaudhury P, Polkinghorne KR, Hawley CM, Johnson DW, Pascoe EM, Irish AB.

Semin Dial. 2018 May;31(3):244-257. doi: 10.1111/sdi.12658. Epub 2017 Nov 26. Review.

PMID:
29178510
32.

Factors associated with patient activation in an Australian population with comorbid diabetes and chronic kidney disease: a cross-sectional study.

Zimbudzi E, Lo C, Ranasinha S, Fulcher GR, Jan S, Kerr PG, Polkinghorne KR, Russell G, Walker RG, Zoungas S.

BMJ Open. 2017 Oct 22;7(10):e017695. doi: 10.1136/bmjopen-2017-017695.

33.

The fragility of significant results underscores the need of larger randomized controlled trials in nephrology.

Shochet LR, Kerr PG, Polkinghorne KR.

Kidney Int. 2017 Dec;92(6):1469-1475. doi: 10.1016/j.kint.2017.05.011. Epub 2017 Jul 26.

PMID:
28754551
34.

The association between patient activation and self-care practices: A cross-sectional study of an Australian population with comorbid diabetes and chronic kidney disease.

Zimbudzi E, Lo C, Ranasinha S, Kerr PG, Polkinghorne KR, Teede H, Usherwood T, Walker RG, Johnson G, Fulcher G, Zoungas S.

Health Expect. 2017 Dec;20(6):1375-1384. doi: 10.1111/hex.12577. Epub 2017 Jul 4.

35.

Fatal Dialysis Vascular Access Hemorrhage.

Jose MD, Marshall MR, Read G, Lioufas N, Ling J, Snelling P, Polkinghorne KR.

Am J Kidney Dis. 2017 Oct;70(4):570-575. doi: 10.1053/j.ajkd.2017.05.014. Epub 2017 Jun 30.

36.

Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab.

Mulley WR, Huang LL, Ramessur Chandran S, Longano A, Amos LAR, Polkinghorne KR, Nikolic-Paterson DJ, Kanellis J.

Clin Transplant. 2017 Sep;31(9). doi: 10.1111/ctr.13037. Epub 2017 Jul 13.

PMID:
28640458
37.

Total volume and composition of fluid intake and mortality in older women: a cohort study.

Lim WH, Wong G, Lewis JR, Lok CE, Polkinghorne KR, Hodgson J, Lim EM, Prince RL.

BMJ Open. 2017 Mar 24;7(3):e011720. doi: 10.1136/bmjopen-2016-011720.

38.

Early serum creatinine accurately predicts acute kidney injury post cardiac surgery.

Grynberg K, Polkinghorne KR, Ford S, Stenning F, Lew TE, Barrett JA, Summers SA.

BMC Nephrol. 2017 Mar 16;18(1):93. doi: 10.1186/s12882-017-0504-y.

39.

Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey.

Evangelidis N, Tong A, Manns B, Hemmelgarn B, Wheeler DC, Tugwell P, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Sautenet B, O'Donoghue D, Tam-Tham H, Youssouf S, Mandayam S, Ju A, Hawley C, Pollock C, Harris DC, Johnson DW, Rifkin DE, Tentori F, Agar J, Polkinghorne KR, Gallagher M, Kerr PG, McDonald SP, Howard K, Howell M, Craig JC; Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Initiative.

Am J Kidney Dis. 2017 Oct;70(4):464-475. doi: 10.1053/j.ajkd.2016.11.029. Epub 2017 Feb 24.

PMID:
28238554
40.

Predicting 6-month mortality risk of patients commencing dialysis treatment for end-stage kidney disease.

Ivory SE, Polkinghorne KR, Khandakar Y, Kasza J, Zoungas S, Steenkamp R, Roderick P, Wolfe R.

Nephrol Dial Transplant. 2017 Sep 1;32(9):1558-1565. doi: 10.1093/ndt/gfw383.

PMID:
28073820
41.

Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.

Irish AB, Viecelli AK, Hawley CM, Hooi LS, Pascoe EM, Paul-Brent PA, Badve SV, Mori TA, Cass A, Kerr PG, Voss D, Ong LM, Polkinghorne KR; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

JAMA Intern Med. 2017 Feb 1;177(2):184-193. doi: 10.1001/jamainternmed.2016.8029.

42.

Can We Predict the Unpredictable after Vascular Access Creation?

Polkinghorne KR, Lok CE.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1729-1731. doi: 10.2215/CJN.08930816. Epub 2016 Sep 14. No abstract available.

43.

Willingness to participate in a randomized trial comparing catheters to fistulas for vascular access in incident hemodialysis patients: an international survey of nephrologists.

Poinen K, Oliver MJ, Ravani P, Van der Veer SN, Jager KJ, Van Biesen W, Polkinghorne KR, Rosenfeld A, Lewin AM, Dulai M, Quinn RR.

Can J Kidney Health Dis. 2016 Jul 13;3:33. doi: 10.1186/s40697-016-0125-6. eCollection 2016.

44.

Low versus high dialysate calcium concentration in alternate night nocturnal hemodialysis: A randomized controlled trial.

Masterson R, Blair S, Polkinghorne KR, Lau KK, Lian M, Strauss BJ, Morgan JG, Kerr P, Toussaint ND.

Hemodial Int. 2017 Jan;21(1):19-28. doi: 10.1111/hdi.12452. Epub 2016 Jun 30.

PMID:
27364375
45.

Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi LS, Ong LM, Irish AB; FAVOURED study team.

Nephrology (Carlton). 2017 Oct;22(10):823-824. doi: 10.1111/nep.12823. No abstract available.

PMID:
27188542
46.

Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.

Zhang L, Lee G, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.

Kidney Int. 2016 Jun;89(6):1337-45. doi: 10.1016/j.kint.2016.02.014. Epub 2016 Apr 8.

PMID:
27165824
47.

Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique Study.

Urquhart-Secord R, Craig JC, Hemmelgarn B, Tam-Tham H, Manns B, Howell M, Polkinghorne KR, Kerr PG, Harris DC, Thompson S, Schick-Makaroff K, Wheeler DC, van Biesen W, Winkelmayer WC, Johnson DW, Howard K, Evangelidis N, Tong A.

Am J Kidney Dis. 2016 Sep;68(3):444-54. doi: 10.1053/j.ajkd.2016.02.037. Epub 2016 Mar 8.

PMID:
26968042
48.

Cystatin C estimated glomerular filtration rate and all-cause and cardiovascular disease mortality risk in the general population: AusDiab study.

Barr EL, Reutens A, Magliano DJ, Wolfe R, Lu ZX, Sikaris KA, Tanamas SK, Atkins R, Chadban S, Shaw JE, Polkinghorne KR.

Nephrology (Carlton). 2017 Mar;22(3):243-250. doi: 10.1111/nep.12759.

PMID:
26938304
49.

How Can the Complications of Central Vein Catheters Be Reduced?: Intraluminal Prophylaxis and Management of Catheter Infections: Role of Antibiotic Locks.

Polkinghorne KR.

Semin Dial. 2016 May;29(3):197-8. doi: 10.1111/sdi.12476. Epub 2016 Feb 14. Review. No abstract available.

PMID:
26875584
50.

Different faces of Nocardia infection in renal transplant recipients.

Shrestha S, Kanellis J, Korman T, Polkinghorne KR, Brown F, Yii M, Kerr PG, Mulley W.

Nephrology (Carlton). 2016 Mar;21(3):254-60. doi: 10.1111/nep.12585.

PMID:
26820918

Supplemental Content

Loading ...
Support Center